201 related articles for article (PubMed ID: 35545181)
1. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
2. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
[TBL] [Abstract][Full Text] [Related]
4. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
5. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Kelly J; Cheng J; Malloy R; Lupi K
J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
[TBL] [Abstract][Full Text] [Related]
8. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
Burkhardt BE; Rücker G; Stiller B
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
[TBL] [Abstract][Full Text] [Related]
10. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Parlow S; Di Santo P; Mathew R; Jung RG; Simard T; Gillmore T; Mao B; Abdel-Razek O; Ramirez FD; Marbach JA; Dick A; Glover C; Russo JJ; Froeschl M; Labinaz M; Fernando SM; Hibbert B;
Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):712-720. PubMed ID: 34382063
[TBL] [Abstract][Full Text] [Related]
11. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK
Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736
[TBL] [Abstract][Full Text] [Related]
12. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
13. No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Prosperi-Porta G; Motazedian P; Di Santo P; Jung RG; Parlow S; Abdel-Razek O; Simard T; Hutson J; Malhotra N; Fu A; Ramirez FD; Froeschl M; Mathew R; Hibbert B;
J Cardiol; 2022 Oct; 80(4):358-364. PubMed ID: 35725945
[TBL] [Abstract][Full Text] [Related]
14. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Jung RG; Di Santo P; Mathew R; Abdel-Razek O; Parlow S; Simard T; Marbach JA; Gillmore T; Mao B; Bernick J; Theriault-Lauzier P; Fu A; Lau L; Motazedian P; Russo JJ; Labinaz M; Hibbert B
J Am Heart Assoc; 2021 Nov; 10(21):e021570. PubMed ID: 34713704
[TBL] [Abstract][Full Text] [Related]
15. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
17. Effects of Inotropes on the Mortality in Patients With Septic Shock.
Sato R; Ariyoshi N; Hasegawa D; Crossey E; Hamahata N; Ishihara T; Nasu M; Devendra G
J Intensive Care Med; 2021 Feb; 36(2):211-219. PubMed ID: 31793373
[TBL] [Abstract][Full Text] [Related]
18. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P; Mathew R; Jung RG; Simard T; Skanes S; Mao B; Ramirez FD; Marbach JA; Abdel-Razek O; Motazedian P; Parlow S; Boczar KE; D'Egidio G; Hawken S; Bernick J; Wells GA; Dick A; So DY; Glover C; Russo JJ; McGuinty C; Hibbert B;
Crit Care; 2021 Aug; 25(1):289. PubMed ID: 34376218
[TBL] [Abstract][Full Text] [Related]
19. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
